Choose your injection site as you normally would
Perioperative considerations With their superiority in glycaemic control, low incidence of fasting hypoglycaemia, roles in weight management, and established evidence for their cardiovascular benefits, GLP-1 agonists present as highly attractive agents in improving patient outcomes in the perioperative setting, with growing interest for these agents to be continued without perioperative interruption
However, once ROS levels exceed the buffering capacity on response to multiple stimuli, a series of adaptive responses that are combined with inflammatory responses followed by intracellular damage are activated, which further lead to progressive mitochondrial dysfunction and cell death [25]
From a pharmacological standpoint, both agents influence insulin sensitivity and glucose homeostasis, albeit through different mechanisms
But the shows treatment of Taylor reflects a culture in which GLP-1s are ubiquitous and normalized, even when their use sometimes leads to extreme and troubling results
Understanding who benefits most helps you make an informed decision with your provider